US Patent

US12398087 — Methods of making bempedoic acid and compositions of the same

Composition of Matter · Assigned to Esperion Therapeutics Inc · Expires 2040-06-19 · 14y remaining

Vulnerability score 17/100 Ironclad — strong claim type, well-established, deep family

What this patent protects

This patent protects methods for making bempedoic acid and compositions containing it, including a pharmaceutical material and methods of treating various diseases and conditions.

USPTO Abstract

The invention provides methods of preparing 8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid and methods of making a pharmaceutical material comprising a purified amount of 8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid. Also provided are compositions and pharmaceutical materials including a purified amount of 8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid as well as methods of treating various diseases and conditions using the compositions and pharmaceutical materials.

Drugs covered by this patent

Patent Metadata

Patent number
US12398087
Jurisdiction
US
Classification
Composition of Matter
Expires
2040-06-19
Drug substance claim
Yes
Drug product claim
Yes
Assignee
Esperion Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.